Package 71656-061-16

Brand: glycopyrrolate

Generic: glycopyrrolate
NDC Package

Package Facts

Identity

Package NDC 71656-061-16
Digits Only 7165606116
Product NDC 71656-061
Description

1 BOTTLE in 1 BOTTLE (71656-061-16) / 473 mL in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2024-11-25
Brand glycopyrrolate
Generic glycopyrrolate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "26be665a-acae-22fd-e063-6394a90a2a0e", "openfda": {"unii": ["V92SO9WP2I"], "rxcui": ["999961"], "spl_set_id": ["3e6f8091-d6fe-4c8f-b897-606a70bf74bc"], "manufacturer_name": ["Saptalis Pharmaceuticals, LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 BOTTLE (71656-061-16)  / 473 mL in 1 BOTTLE", "package_ndc": "71656-061-16", "marketing_start_date": "20241125"}], "brand_name": "glycopyrrolate", "product_id": "71656-061_26be665a-acae-22fd-e063-6394a90a2a0e", "dosage_form": "SOLUTION", "pharm_class": ["Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]", "Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "71656-061", "generic_name": "glycopyrrolate", "labeler_name": "Saptalis Pharmaceuticals, LLC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "glycopyrrolate", "active_ingredients": [{"name": "GLYCOPYRROLATE", "strength": "1 mg/5mL"}], "application_number": "ANDA216297", "marketing_category": "ANDA", "marketing_start_date": "20241125", "listing_expiration_date": "20261231"}